GPO-L-ONE
Product Description
The Government Pharmaceutical Organization (GPO)
-
Country/Region:Thailand
-
On CPHI since:2015
-
Certificates:1
-
Employees:1000 - 4999
Company types
Primary activities
Categories
Specifications
The Government Pharmaceutical Organization (GPO)
-
Country/Region:Thailand
-
On CPHI since:2015
-
Certificates:1
-
Employees:1000 - 4999
Company types
Primary activities
More Products from The Government Pharmaceutical Organization (GPO) (2)
-
Product DALAVIR
Dolutegravir/Lamivudine/Tenofovir disoproxil fumarate 50/300/300 mg
Dolutegravir increases the immune cells that help fight infections in the body and decreases the amount of HIV in the blood.
WHO recommends Dolutegravir as preferred HIV treat... -
Product TEDAVIR
Dolutegravir/Emtricitabine/Tenofovir Alafenamide Tablets 50/200/25 mg are indicated for use as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 40 kg. In addition to being used for treatment. The product is smal...
